Characteristics of Peripheral and Peritoneal Lymphocytes from Continuous Ambulatory Peritoneal Dialysis Patients
暂无分享,去创建一个
[1] M. Leffell,et al. Chronic T-Lymphocyte Activation in Chronic Renal Failure: A Study of Hemodialysis, Capd and Pre-Dialysis Patients , 1992, The International journal of artificial organs.
[2] G. Malatesta,et al. Multiple sclerosis: an immune system activation disease. , 1991, Acta neurologica.
[3] R. Krediet,et al. The Mesothelial Cells in CAPD Effluent and Their Relation to Peritonitis Incidence , 1991, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[4] S. Raziuddin,et al. Immune activation and T cell subset abnormalities in circulation of patients with recently diagnosed type I diabetes mellitus , 1990, Clinical and experimental immunology.
[5] S. Lewis,et al. Comparison of peritoneal white blood cell parameters from continuous ambulatory peritoneal dialysis patients with a high or low incidence of peritonitis. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[6] F. Port. Mortality and causes of death in patients with end-stage renal failure. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[7] S. Davies. Peritoneal lymphocyte populations in CAPD patients. , 1990, Contributions to nephrology.
[8] P. Giordano,et al. Analysis of cellular populations in peritoneal effluents of children on CAPD. , 1989, Clinical nephrology.
[9] S. Davies,et al. Activation of immunocompetent cells in the peritoneum of patients treated with CAPD. , 1989, Kidney international.
[10] J. Briggs,et al. Longitudinal Study of Peritoneal Defence Mechanisms in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD) , 1989, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[11] D. Adu,et al. T-cell-independent and T-cell-dependent antibody responses in patients with chronic renal failure. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] B. Brando,et al. Flow cytometric study of immunocompetent cell phenotypes and phagocytosis in CAPD effluent. , 1988, ASAIO transactions.
[13] S. Carozzi,et al. Interferon-γ (IFN-γ) as In Vitro Enhancing Factor of Peritoneal Macrophage Defective Bactericidal Activity During Continuous Ambulatory Peritoneal Dialysis (CAPD) , 1988 .
[14] H. J. Bos,et al. Distinct Subpopulations of Elicited Human Macrophages in Peritoneal Dialysis Patients and Women Undergoing Laparoscopy: A Study on Peroxidatic Activity , 1988, Journal of leukocyte biology.
[15] T. Huang,et al. Serial cell-mediated immunological changes in terminal uremic patients on continuous ambulatory peritoneal dialysis therapy. , 1988, American journal of nephrology.
[16] D. Han,et al. Studies on lymphocyte subpopulations and cell-mediated immunity in patients with chronic renal failure. , 1988, Yonsei medical journal.
[17] W. Weimar,et al. Intact humoral immune response in patients on continuous ambulatory peritoneal dialysis. , 1988, Nephron.
[18] J. Briggs,et al. In vitro analysis of B lymphocyte function in uraemia. , 1987, Clinical and experimental immunology.
[19] N. Letvin,et al. A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. , 1987, The Journal of clinical investigation.
[20] J. Briggs,et al. Bactericidal activity of peritoneal macrophages from continuous ambulatory dialysis patients. , 1987, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[21] G. Boner,et al. Cell-mediated immunity in uremic patients prior to and after 6 months' treatment with continuous ambulatory peritoneal dialysis. , 1986, Israel journal of medical sciences.
[22] K. Meyer zum Büschenfelde,et al. Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect. , 1986, Kidney international.
[23] V. Debari,et al. Surface Marker Characterization of Peritoneal Dialysis Patients’ Intraperitoneal Leukocytes by Monoclonal Antibodies , 1986 .
[24] E. Langhoff,et al. Effect of interleukin-2 and methylprednisolone on in vitro transformation of uremic lymphocytes. , 1986, International archives of allergy and applied immunology.
[25] J. Young,et al. Nutrition and delayed hypersensitivity during continuous ambulatory peritoneal dialysis in relation to peritonitis. , 1986, Nephron.
[26] W. Keane,et al. Antimicrobial activities of dialysate-elicited and resident human peritoneal macrophages , 1985, Infection and immunity.
[27] G. Piccoli,et al. Association between human lymphocyte antigens B8, DR3 and response to peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. , 1985, Nephron.
[28] E. Neilson,et al. Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients. , 1984, Kidney international.
[29] M. Formica,et al. Improved Cell-Mediated Immunity in CAPD Patients as Compared to those on Hemodialysis , 1984 .
[30] G. Piccoli,et al. Lymphocyte Subsets Assayed by Numerical Tests in CAPD , 1984, The International journal of artificial organs.
[31] W. Keane,et al. Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis. , 1983, The Journal of infectious diseases.
[32] M. Zembala,et al. Output of Peritoneal Cells into Peritoneal Dialysate , 1983 .
[33] E. Langhoff,et al. Improved lymphocyte transformation in vitro of patients on continuous ambulatory peritoneal dialysis. , 1983, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.
[34] D. De Francesco,et al. Continuous ambulatory peritoneal dialysis and cellular immunity. , 1983, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.
[35] A. Pesce,et al. Preliminary observations on the laboratory markers of cell-mediated immunity in patients transferring from hemodialysis to continuous ambulatory peritoneal dialysis. , 1983, Contributions to nephrology.
[36] G. Piccoli,et al. Continuous ambulatory peritoneal dialysis improves immunodeficiency in uremic patients. , 1983, Nephron.
[37] R. Coppo,et al. The Influence of Peritoneal Dialysis on Cellular Immunity , 1981 .
[38] V. Farewell,et al. High incidence of neoplasia in uremic patients receiving long-term dialysis. Cancer and long-term dialysis. , 1981, Nephron.
[39] R. Ganguly,et al. Studies of human peritoneal cells: a normal saline lavage technique for the isolation and characterization of cells from peritoneal dialysis patients. , 1980, Journal of the Reticuloendothelial Society.
[40] E. Lustbader,et al. Host responses to hepatitis B infection in patients in a chronic hemodialysis unit. , 1977, Kidney international.
[41] G. A. Sutherland,et al. Increased incidence of malignancy in chronic renal failure. , 1977, Nephron.
[42] A. Pasternack,et al. Skin test sensitivity and antigen-induced lymphocyte transformation in uraemia. , 1973, Clinical and experimental immunology.
[43] J. Mannick,et al. Renal transplantation in azotemic dogs. , 1960, Surgery.